PRPO

Precipio, Inc. · NASDAQ

Sector Health Services
Industry Medical/Nursing Services
Website recipiodx.com
Employees(FY) 53
ISIN US74019L6020

Performance

+8.94%

1W

-5.41%

1M

-4.41%

3M

-18.32%

6M

-3.23%

YTD

-48.44%

1Y

Profile

Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; HemeScreen, a suite of robust genetic diagnostic panels; and COVID-19 antibody tests. It sells ICE- technology kits to bio-pharma customers. The company is based in New Haven, Connecticut.

Advanced Technical Analysis

Technical Analysis of PRPO 2024-05-10

Overview: In analyzing the technical indicators for PRPO over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive assessment of the stock's potential price movement. By examining these key factors, we aim to offer valuable insights and predictions for the next few days.

Trend Indi...

See more ...

Recent News & Updates

2024-05-14 20:52
PRPO Stock Earnings: Precipio Misses EPS, Misses Revenue for Q1 2024(Investorplace)
2024-05-06 05:00
Precipio Secures a short-term $500K Credit Facility(Globenewswire)
2024-03-31 22:53
PRPO Stock Earnings: Precipio Beats EPS, Misses Revenue for Q4 2023(Investorplace)
2024-03-25 05:00
Precipio Announces Year end 2023 Shareholder Update Call(Globenewswire)
2024-02-12 21:00
Precipio to Report $15.2M for FY-2023 (unaudited) Revenues, an increase of 60% YoY(Globenewswire)
2024-02-05 21:00
Precipio and Cardinal Health Sign Distribution Agreement for its HemeScreen Portfolio of Molecular assays for Cancer(Globenewswire)
2024-01-22 21:00
Precipio's Q4-2023 Cash Burn From Operations (unaudited) drops below $100K for the full quarter(Globenewswire)
2024-01-16 21:30
Precipio Signs Distribution Agreement For IV-Cell and HemeScreen in Japan(Globenewswire)
2024-01-01 20:00
Precipio Announces Christina Valauri joins the Board of Directors(Globenewswire)
2023-12-14 03:30
Precipio Management Shares Thoughts on 2023, and Looks Ahead To 2024(Globenewswire)
2023-11-16 04:00
Precipio Announces Q3-2023 Shareholder Update Call(Yahoo Finance)
2023-10-17 21:00
Precipio to Report $4.5M Q3-2023 Revenues, Double From Q3-2022(Globenewswire)
2023-10-02 22:00
Precipio's Q3 Cash Burn From Operations (unaudited) Declines 59% YoY, from $2.5M in Q3-2022 to approximately $1M in Q3-2023(Globenewswire)
2023-09-27 21:00
Precipio Continues to Sign New HemeScreen Customers(Globenewswire)
2023-09-24 23:00
Precipio Reduces Product Revenue Result Needed for Cash Flow Breakeven(Yahoo Finance)
2023-09-20 21:00
Precipio Takes Final Step Towards Regaining Nasdaq Compliance(Yahoo Finance)
2023-09-12 21:30
Precipios Pathology Division Exceeds Breakeven Revenues in August, Four Months Ahead of Plan(Yahoo Finance)
2023-08-31 03:26
11 ChatGPT Penny Stock Picks(Yahoo Finance)
2023-08-18 18:01
Precipio, Inc. (NASDAQ:PRPO) Q2 2023 Earnings Call Transcript(Yahoo Finance)
2023-08-12 22:16
Precipio, Inc.'s (NASDAQ:PRPO) Shares Not Telling The Full Story(Yahoo Finance)
2023-08-10 05:00
Precipio Announces Q2-2023 Shareholder Update Call(Yahoo Finance)
2023-08-07 21:00
Precipio Launches Its Much-Anticipated Quantitative BCR-ABL 2.0 Panel(Yahoo Finance)
2023-08-02 21:00
Precipios Operational Efficiency Measures Continue To Reduce Cash Burn And Move The Company Towards Breakeven(Yahoo Finance)
2023-07-31 21:00
Precipio Unaudited Q2-2023 Revenues Show combined increase of 25% over Q1-2023(Yahoo Finance)
2023-06-13 21:49
Precipios Omnia Methodology Enables Diagnosis of MDS With Peripheral Blood Instead of Bone Marrow Biopsy(Yahoo Finance)
2023-06-12 21:00
Precipio Enters into Collaboration with Prestigious New York-based Institution to Develop Revolutionary Brain Tumor Panel using HemeScreen® Technology(Yahoo Finance)
2023-06-07 20:30
Precipio, Inc. Announces Pricing of $2 Million Registered Direct Offering and Concurrent Private Placement(Yahoo Finance)
2023-06-06 21:30
Projected cash burn reduced by $1.5 million annually from Three Operational Efficiency Projects(Yahoo Finance)
2023-05-21 23:00
Precipios Lab Detects BCR-ABL1 Oncogene Co-Expression of p190 & p210 Isoforms in a CML Patient By Using HemeScreen® Technology(Yahoo Finance)
2023-05-17 04:00
Precipio Shares Growth Catalysts For HemeScreen(Yahoo Finance)

Page 1 of 4

previousnext